Anthropic Flags Bioweapon Misuse as Altman Urges AI Pause

common.time_ago.hour

Newsroom

How were AI models almost misused for biological weapon research?

How has this incident affected AI companies' IPO plans and investments?

What changes are occurring in AI industry regulation and safety policies due to this incident?

Anthropic Flags Bioweapon Misuse as Altman Urges AI Pause — Image source: Unblock Media

Anthropic’s report revealed multiple bioweapon research attempts using Claude models, sparking industry and legislative action
OpenAI and lawmakers responded with calls for mandatory regulation and project suspensions, signaling a shift in AI governance

On September 11, 2026, Bloomberg reported that OpenAI CEO Sam Altman called on major artificial intelligence labs to voluntarily pause the release of their most advanced models. The move followed Anthropic’s disclosure that state-linked actors had attempted to leverage its Claude AI for bioweapons research. Both OpenAI and Anthropic confirmed the suspension of select internal projects amid increasing safety concerns and pressure from government officials.

Anthropic's 154-page threat intelligence report documented five distinct efforts by actors from unsupported regions to exploit Claude for biological weapons research. The report’s findings intensified debate over whether advanced AI risks now outweigh potential benefits.

Altman’s appeal for a coordinated pause acknowledged inconsistent participation among rival labs but marked a notable industry shift in response to safety threats.

Following these developments, California enacted new laws—SB 813, AB 1405, and AB 1864—targeting AI-enabled biological threats, with signatures from Governor Gavin Newsom. Senator Bernie Sanders introduced federal legislation calling for a mandated pause on advanced AI development and a ban on artificial superintelligence.

The responses from industry and legislators indicated a move toward state and national oversight. OpenAI now advocates for Congress to require independent safety testing, model evaluations, and mandatory incident reporting for advanced AI systems to prevent bioweapon scenarios.

These events have accelerated regulatory activity, marking a pivotal moment for AI governance and underscoring heightened urgency around AI safety, public trust, and the technology sector’s investment climate, according to Bloomberg.